4-[5-[7-(imidazo[4,5-b]pyridin-3-ylmethyl)-5-methoxy-2,3-dihydro-1,4-benzodioxin-3-yl]-2-pyridinyl]morpholine
C25H25N5O4 — CID 137405179
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[5-[7-(imidazo[4,5-b]pyridin-3-ylmethyl)-5-methoxy-2,3-dihydro-1,4-benzodioxin-3-yl]-2-pyridinyl]morpholine
4-[5-[7-(imidazo[4,5-b]pyridin-3-ylmethyl)-5-methoxy-2,3-dihydro-1,4-benzodioxin-3-yl]-2-pyridinyl]morpholine (PubChem CID 137405179) has the molecular formula C25H25N5O4 and a molecular weight of 459.51 g/mol. Its IUPAC name is 4-[5-[7-(imidazo[4,5-b]pyridin-3-ylmethyl)-5-methoxy-2,3-dihydro-1,4-benzodioxin-3-yl]-2-pyridinyl]morpholine.
Molecular Properties
| Compound Name | 4-[5-[7-(imidazo[4,5-b]pyridin-3-ylmethyl)-5-methoxy-2,3-dihydro-1,4-benzodioxin-3-yl]-2-pyridinyl]morpholine |
|---|---|
| PubChem CID | 137405179 |
| Molecular Formula | C25H25N5O4 |
| Molecular Weight | 459.51 g/mol |
| Exact Mass | 459.19 |
| IUPAC Name | 4-[5-[7-(imidazo[4,5-b]pyridin-3-ylmethyl)-5-methoxy-2,3-dihydro-1,4-benzodioxin-3-yl]-2-pyridinyl]morpholine |
| SMILES | COc1cc(Cn2cnc3cccnc32)cc2c1OC(c1ccc(N3CCOCC3)nc1)CO2 |
| InChI | InChI=1S/C25H25N5O4/c1-31-20-11-17(14-30-16-28-19-3-2-6-26-25(19)30)12-21-24(20)34-22(15-33-21)18-4-5-23(27-13-18)29-7-9-32-10-8-29/h2-6,11-13,16,22H,7-10,14-15H2,1H3 |
| InChIKey | JYMNJQXTXZIUQE-UHFFFAOYSA-N |
| XLogP | 3.23 |
| TPSA | 83.76 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 459.51 |
| LogP ≤ 5 | 3.23 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 137405179 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.